Related Experiment Video

Updated: Aug 9, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

23.2K

Botulinum toxin for Raynaud's phenomenon associated with systemic sclerosis: comment on the article by Senet et al

Hanlin Yin1, Bei Liu1, Qianqian Li1

  • 1Department of Rheumatology Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Arthritis & Rheumatology (Hoboken, N.J.)
|October 9, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.6K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.4K

Related Experiment Videos

Last Updated: Aug 9, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

23.2K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.6K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.4K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Articles linked to this work by shared authors, journal, and citation graph.

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Pregnancy Loss History Is Associated with Systemic Involvement and Disease Activity in Women with Behçet's Disease: A Retrospective Cohort Study.

Diagnostics (Basel, Switzerland)·2026

Imaging-Guided Macrophage-Targeted Nanotheranostics for Rheumatoid Arthritis.

ACS applied materials & interfaces·2026

Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC).

Rheumatology (Oxford, England)·2025

Global, regional, and national burdens of psoriasis in adolescents and young adults: a trend analysis based on the global burden of disease.

Clinical rheumatology·2025

Deubiquitination of aryl hydrocarbon receptor by USP21 negatively regulates T helper 17 cell differentiation.

Journal of leukocyte biology·2024

CASTOR1 regulates humoral immune responses and contributes to the pathogenesis of systemic lupus erythematosus.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Early synovial regulatory T cell engagement in posttraumatic osteoarthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Down-Regulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis Via a Galectin-3/mTOR Dependent Pathway.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Development and temporal validation of AI-enhanced HEp-2 indirect immunofluorescence image analysis for specific autoantibody prediction in systemic autoimmune rheumatic diseases.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Whole-Brain Monosynaptic Inputs to and Axonal Projections From Posterior Insular Cortex GABAergic Neurons in Mice.

CNS neuroscience & therapeutics·2026

ASIC currents in cultured primate retinal rod and cone cells.

Pflugers Archiv : European journal of physiology·2026

Handheld cochlear nerve action potential mapping for real-time functional navigation in vestibular schwannoma surgery.

Journal of neurosurgery·2026

Molecular target for neuroinflammation and pain management: transient receptor potential vanilloid 1.

Inflammopharmacology·2026

Neuroimmune pharmacotherapy across the skin-brain axis: mechanisms, therapeutic targets, and AI-enabled precision approaches.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Whole-blood miRNA candidate prioritization for longitudinal pain change suggests synaptic and neuronal organization pathway involvement in early rheumatoid arthritis.

Molecular pain·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us